Stay updated on Pembrolizumab Combo in Ovary Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovary Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3 revision.
    Difference
    0.0%
    Check dated 2026-03-20T19:55:49.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Added the Ovarian cancer topic and a MedlinePlus Genetics related topic, and updated the revision from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-06T18:31:07.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Ovarian cancer and the MedlinePlus Genetics related topic were removed from the page's related topics.
    Difference
    0.1%
    Check dated 2026-02-27T18:46:52.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 removed; this is a minor UI revision with no impact on study content, eligibility, enrollment, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:39:00.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now shown, replacing v3.4.0. No study content or eligibility criteria appear to be changed.
    Difference
    0.0%
    Check dated 2026-02-05T13:23:19.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The changes add a Show glossary option and standardize metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). These updates do not alter core study content, eligibility, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T07:57:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovary Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovary Cancer Clinical Trial page.